We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Herbalife
HLF
$1.23B
| $16.5K | ﹤0.01% |
1,256
+138
| +12% | +$1.9K |
|
2027
Virtus Investment Partners
VRTS
$1.11B
| $16.5K | ﹤0.01% |
115
| – | – |
|
2028
REX American Resources
REX
$1.46B
| $16.4K | ﹤0.01% |
364
| – | – |
|
|
INVX
2029
Innovex International
INVX
$1.87B
| $16.4K | ﹤0.01% |
662
| – | – |
|
2030
CarMax
KMX
$8.27B
| $16.4K | ﹤0.01% |
310
-350
| -53% | -$15.2K |
|
2031
Chewy
CHWY
$8.54B
| $16.4K | ﹤0.01% |
834
+228
| +38% | +$5.18K |
|
2032
Yext
YEXT
$501M
| $16.3K | ﹤0.01% |
3,492
-2,370
| -40% | -$9.2K |
|
2033
JetBlue
JBLU
$1.96B
| $16.3K | ﹤0.01% |
2,842
| – | – |
|
2034
Cipher Digital
CIFR
$9.47B
| $16.3K | ﹤0.01% |
664
+551
| +488% | +$11.6K |
|
2035
Rigetti Computing
RGTI
$4.7B
| $16.2K | ﹤0.01% |
840
+767
| +1,051% | +$14.8K |
|
2036
NerdWallet
NRDS
$584M
| $16.2K | ﹤0.01% |
1,749
+1,053
| +151% | +$9.86K |
|
2037
LSI Industries
LYTS
$853M
| $16.2K | ﹤0.01% |
608
+121
| +25% | +$2.8K |
|
2038
Caledonia Mining Corp
CMCL
$360M
| $16.2K | ﹤0.01% |
+846
| New | +$19.2K |
|
2039
Alaska Air
ALK
$5.15B
| $16K | ﹤0.01% |
307
-286
| -48% | -$12.2K |
|
2040
Southern First Bancshares
SFST
$582M
| $16K | ﹤0.01% |
262
| – | – |
|
2041
Grid Dynamics Holdings
GDYN
$476M
| $16K | ﹤0.01% |
2,818
-2,811
| -50% | -$17.4K |
|
2042
Inhibrx
INBX
$1.2B
| $15.9K | ﹤0.01% |
168
| – | – |
|
2043
IMAX
IMAX
$2.38B
| $15.9K | ﹤0.01% |
398
| – | – |
|
2044
AvalonBay Communities
AVB
$27.1B
| $15.8K | ﹤0.01% |
84
+44
| +110% | +$7.95K |
|
2045
Neogen
NEOG
$2.05B
| $15.8K | ﹤0.01% |
1,761
-2,240
| -56% | -$20.6K |
|
2046
Scholar Rock
SRRK
$5.71B
| $15.8K | ﹤0.01% |
287
+159
| +124% | +$7.68K |
|
2047
American Financial Group
AFG
$11.9B
| $15.7K | ﹤0.01% |
112
+50
| +81% | +$6.63K |
|
2048
Portillo's
PTLO
$315M
| $15.7K | ﹤0.01% |
3,305
-2,733
| -45% | -$13.2K |
|
2049
Dave Inc
DAVE
$5.12B
| $15.6K | ﹤0.01% |
42
+30
| +250% | +$7.8K |
|
2050
First Merchants
FRME
$2.72B
| $15.6K | ﹤0.01% |
358
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.